Generic drugs the pay-for-delay problem /

Les prix des medicaments sur un marche global politiques et enjeux.
出版事項: (2008)

Generic drugs needs and issues /
出版事項: (2009)

Generic drugs needs and issues /
出版事項: (2009)

The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
出版事項: (1983)

The competitive status of the U.S. pharmaceutical industry the influences of technology in determining international industrial competitive advantage /
出版事項: (1983)

The $800 million pill the truth behind the cost of new drugs /
著者:: Goozner, Merrill, 1950-
出版事項: (2004)

The $800 million pill the truth behind the cost of new drugs /
著者:: Goozner, Merrill, 1950-
出版事項: (2004)

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
著者:: Osmane, Malik
出版事項: (2014)

Rift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account /
著者:: Osmane, Malik
出版事項: (2014)

Driving down the cost of drugs : battling big pharma in the statehouse /
著者:: Castellblanch, Ram�on, 1948-
出版事項: (2012)

Driving down the cost of drugs : battling big pharma in the statehouse /
著者:: Castellblanch, Ram�on, 1948-
出版事項: (2012)

Pharmaceutical economics and policy
著者:: Schweitzer, Stuart O.
出版事項: (2007)

Pharmaceutical economics and policy
著者:: Schweitzer, Stuart O.
出版事項: (2007)

The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
出版事項: (2003)

The WetFeet insider guide to the top 20 biotechnology and pharmaceutical firms /
出版事項: (2003)

Profits before people? ethical standards and the marketing of prescription drugs /
著者:: Weber, Leonard J., 1942-
出版事項: (2006)

Profits before people? ethical standards and the marketing of prescription drugs /
著者:: Weber, Leonard J., 1942-
出版事項: (2006)

Marketing strategies adopted by generic and original drugs companies in an effort to attain strategic competitiveness: a study of Mombasa /
著者:: Matingi, Ireen Mueni
出版事項: (2013)

CAPA for the FDA-regulated industry /
著者:: Rodríguez Pérez, José, 1961-
出版事項: (2010)

CAPA for the FDA-regulated industry /
著者:: Rodríguez Pérez, José, 1961-
出版事項: (2010)

The risks of prescription drugs
出版事項: (2010)

The risks of prescription drugs
出版事項: (2010)

ADME-enabling technologies for drug design and development
出版事項: (2012)

ADME-enabling technologies for drug design and development
出版事項: (2012)

Drug discovery and design medical aspects /
出版事項: (2002)

Drug discovery and design medical aspects /
出版事項: (2002)

Drugs : from discovery to approval /
著者:: Ng, Rick
出版事項: (2015)

Drugs : from discovery to approval /
著者:: Ng, Rick
出版事項: (2015)

Drug discovery practices, processes, and perspectives /
出版事項: (2013)

Drug discovery practices, processes, and perspectives /
出版事項: (2013)

Modern drug synthesis
出版事項: (2010)

Successful drug discovery.
出版事項: (2015)

The art of drug synthesis
出版事項: (2007)

Chemical drug design /
出版事項: (2016)

Modern drug synthesis
出版事項: (2010)

The art of drug synthesis
出版事項: (2007)